Crescita Therapeutics (TSE:CTX) Sets New 1-Year High – Here’s Why

Shares of Crescita Therapeutics Inc. (TSE:CTX) reached a new 52-week high during mid-day trading on Wednesday . The company traded as high as C$0.77 and last traded at C$0.77, with a volume of 43000 shares trading hands. The stock had previously closed at C$0.76.

Crescita Therapeutics Price Performance

The company has a debt-to-equity ratio of 17.34, a current ratio of 2.80 and a quick ratio of 2.29. The stock’s fifty day simple moving average is C$0.72 and its 200-day simple moving average is C$0.56. The company has a market capitalization of C$14.15 million, a P/E ratio of 37.50 and a beta of -1.34.

Crescita Therapeutics (TSE:CTX) last released its quarterly earnings results on Monday, May 11th. The company reported C($0.06) earnings per share (EPS) for the quarter. Crescita Therapeutics had a negative net margin of 1.38% and a negative return on equity of 2.07%. The firm had revenue of C$5.64 million for the quarter.

About Crescita Therapeutics

Crescita Therapeutics Inc is a Canadian commercial dermatology company with in-house research & development and manufacturing capabilities. The company offers a portfolio of non-prescription skincare products and early to commercial-stage prescription drug products and owns multiple proprietary drug delivery platforms that support the development of patented formulations that can facilitate the delivery of active ingredients into or through the skin. The firm generates its revenue in the form of product sales and out-licensing revenue.